Last verified: April 2026
State Fees
Utah’s program is statutorily self-funded — patient and licensee fees flow into the Qualified Patient Enterprise Fund (DHHS) and the Qualified Production Enterprise Fund (UDAF). After multiple years of fund surpluses, the legislature lowered patient fees in 2025:
| Fee | Before July 1, 2025 | Current |
|---|---|---|
| State patient card fee (annual) | $15 | $8 |
| Per-transaction fee at pharmacy | $3 | $1.50 |
| Caregiver card fee | $15 | $8 |
| Non-resident visitor card | $15 | $15 |
Provider Visit Costs
The largest cost in the certification process is the provider visit, which is market-driven and not capped by the state. Reported ranges:
- Range: $10 – $500
- Average initial visit: $190
- Average renewal visit: $129
- Mid-2025 typical upfront cost: ~$133 (after SB 64 took effect)
SB 64 (2025) and the End of Card-Drives
Through 2024, low-income patients could obtain certification at organized “card drives” held in the parking lots of medical cannabis pharmacies for around $75. SB 64 banned any card-drive operation within 500 feet of a licensed pharmacy, effectively eliminating the model. Utah Patients Coalition’s Desiree Hennessy called the change “a heartbreaking loss” for low-income access. Effective patient evaluation cost rose to $100–$200.
A medical cannabis pharmacy may not allow a recommending medical provider to evaluate qualified patients on the licensed premises of the pharmacy or within 500 feet of the licensed premises.
Utah Code §26B-4-228 — Pharmacy Practice Limitations
SB 121 (2026) — Patient-Assistance Vouchers
SB 121 (2026) created a $300,000-per-year patient-assistance voucher program, partly in response to the SB 64 fallout. Vouchers offset card fees and contributing provider visit costs for low-income, veteran, and senior patients. Implementation is administered through the Center for Medical Cannabis with funds drawn from the Qualified Patient Enterprise Fund.
Insurance and Tax
Cannabis is not covered by any health insurance. Because cannabis remains a federal Schedule I controlled substance, no insurer — private, Medicare, Medicaid, or VA — will reimburse purchases or evaluations. This pushes the entire cost onto the patient.
Sales tax structure:
- 4.70% Utah state sales tax (the standard general rate)
- 0.0025% medical cannabis assessment fee (funds research and program oversight)
- No separate cannabis excise tax — unlike most adult-use legal states
This is one of the most patient-friendly tax structures in any legal cannabis state — a deliberate decision to keep the program affordable now that fees have dropped.
Average Patient Spend
CMC and industry-tracked data put typical Utah patient monthly spend at $160–$200. Statewide aggregate sales:
| Year | Total Sales | YoY Change |
|---|---|---|
| 2023 | ~$143M | |
| 2024 | ~$157M | +10% |
| 2025 | $175–176M | +12% |
| March 2026 (single month) | $16.3M | |
| Q1 2026 (cumulative) | ~$50M | +12% YoY |
Total First-Year Cost Estimates
For a typical adult patient on a chronic-pain qualification, the total first-year out-of-pocket cost (excluding monthly product spend) ranges roughly:
- Lowest path: $8 card + $100 evaluation + $1.50/transaction = ~$110+
- Typical path: $8 card + $190 initial visit + $129 renewal at six months + transaction fees = ~$340
- Highest path: $8 card + $500 specialty evaluation + multiple transaction fees = ~$550+
None of this is reimbursable by insurance.
Explore Related Topics
Official Sources
- CMC — Patient Fees
- Utah Code §26B-4-228 — Pharmacy Practice Limitations
- SB 64 (2025) — Pharmacy Operations Amendments
For in-depth cannabis education, dosing guides, safety information, and research summaries, visit our partner site TryCannabis.org